The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disorders
Jacquemin, M., Toelen, J., Schoeters, J., van Horenbeeck, I., Vanlinthout, I., Debasse, M., Peetermans, M., Vanassche, T., Peerlinck, K., van Ryn, J., Verhamme, P.Volume:
13
Language:
english
Journal:
Journal of Thrombosis and Haemostasis
DOI:
10.1111/jth.13138
Date:
November, 2015
File:
PDF, 185 KB
english, 2015